msh2 deletions also lead to an increased frequency of mutations conferring anti-fungal resistance in an in vivo model of mouse candidiasis, and analysis of serial clinical isolates showed that the msh2 mutations preceded the emergence of this anti-fungal drug resistance [32]. The gene discussed is MSH2; the disease is candidiasis.